Should you pass or buy Cronos? Zacks experts tell all in a new free Special Report. Free report pulls back the curtain on what's happening with Cronos. Grab your free copy.
Search results
Jul 6, 2023 · Cronos Group Inc , the Canadian cannabis producer backed by cigarette maker Altria Group Inc , confirmed on Thursday it is in talks with potential buyers to explore a sale of the company, after ...
Cronos Group is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes ...
3 days ago · Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
May 9, 2024 · Cannabis-flower revenue jumped 33.5% to $17.53 million, and cannabis-extracts revenue rose 22.6% to $7.73 million. The cost of sales rose by less than revenue, up 25.6% to $20.81 million, to push ...
VFF Village Farms International, Inc. 0.9100. +0.33%. Find the latest Cronos Group Inc. (CRON) stock quote, history, news and other vital information to help you with your stock trading and investing.
Oct 10, 2024 · 08 August 2024 at 8:30 AM EDT. Cronos Group Second Quarter 2024 Earnings Conference Call. View all. Events. 08 August 2024 at 8:30 AM EDT. Cronos Group Second Quarter 2024 Earnings Conference Call. View all. Contact Investor Relations. investor.relations@thecronosgroup.com.
People also ask
Does Cronos sell medical cannabis?
Is Cronos a good stock to buy?
Who is Cronos Group?
Could Cronos Group buy Altria Group Inc?
What does Cronos do?
What brands does Cronos own?
Mar 4, 2024 · Altria's (MO) $1.8 billion investment in Cronos in 2018, which currently gives Altria a 41.4% stake in Cronos, has yet to pay off, as Cronos has had negative operating cash flow over the past five ...